AI and Drug Discovery

James and Eric discuss the potential for AI to revolutionize pharmaceutical discovery, specifically predicting whether Google can identify a novel compound that passes phase one trials within a year. Both express skepticism about the speed of drug approvals, emphasizing that human systems and real-world experiments are significant barriers that AI alone cannot overcome. Despite the allure of rapid advancements, they ultimately lean towards the belief that the timeline remains lengthy and complex.